Entera Bio Ltd (ENTX) Company Profile & Statistics

Entera Bio Ltd
ENTX
(Nasdaq - US)
Closed
1.78
+0.00 (0.00%)
in:usd•As of: Nov 05, 2024 15:59 UTC -5
Open
1.79
High
1.79
Low
1.78

About Entera Bio Ltd

CEO

Miranda Toledano

Headquarters

kiryat hadassah, minrav building, fifth floor

jerusalem, l3 9112002, israel

Auditor

Kesselman & Kesselman

Employees

Share Holders

Website

www.enterabio.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.

Entera Bio Ltd Statistics

Valuation Measures

Market Capitalization ²	63.69M
Enterprise Value	54.63M
Enterprise Value/EBITDA (ttm)	-6.41
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	7.55
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	3.95%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-940.79%
Return on Equity (ttm)	-100.37%
Return on Invested Capital (ttm)	-105.26%
Return on Assets (ttm)	-84.09%

Income Statement

Revenue (ttm)	57.00K
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	9.00K
EBITDA (ttm)³	-8.52M
Net Income Avi to Common (ttm)	-8.54M
Diluted EPS (ttm)	-0.26

Share Statistics

Beta (5Y Monthly)	1.58
52-Week Change	187.10%
S&P500 52-Week Change	32.45%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	36.32M
Dividend Yield	0.00%
Float ⁴	31.88M
% Held by Insiders	10.90%
% Held by Institutions	14.11%

Balance Sheet

Total Cash (mrq)	9.06M
Total Cash Per Share (mrq)	0.25
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	7.42%
Quick Ratio (mrq)	7.41%
Book Value Per Share (mrq)	0.23

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.09
Free Cash Flow (ytd)	-3.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Entera Bio Ltd

Trade With A Regulated Broker